New approaches to obesity treatment are emerging as scientists target underexplored metabolic pathways with the help of artificial intelligence. Demand for better obesity medicines is rising quickly, ...

In this video, Melissa Shoemaker, MD, MPH, discusses how the obesity treatment landscape has changed in recent years.

Obesity treatment has entered a new era with innovative medications offering transformative results. Yet, a troubling reality persists: many who need these life-changing treatments most face the ...

By Hugo Francisco de Souza Can combining two gut hormone pathways unlock better obesity treatments? In the first human trial ...

Tirzepatide is one of the drugs that has revolutionized the treatment of obesity and other conditions such as diabetes in recent years. Despite its clinical success, its precise molecular and cellular ...

An international research group has examined how many people are affected by preclinical and clinical obesity and what health ...

Children who respond well to pediatric obesity treatment have markedly lower morbidity and mortality risks in young adulthood, according to data published on January 21 in JAMA Pediatrics. Researchers ...

The market for obesity treatment is expected to expand more than fifteenfold by 2030 due to escalating competition, fueled by clinical data not only from Novo Nordisk and Eli Lilly but also from other ...

The CagriSema study results are a setback for the Danish drugmaker in its efforts to regain ground lost to Eli Lilly in the obesity-drug market.

Eli Lilly has rolled out a multi-dose KwikPen version of tirzepatide, marketed as Zepbound, for chronic weight management—signaling a packaging update for one of the obesity market’s fastest-expanding ...

Canada is recognized globally for its world-leading obesity care guidelines — yet Canadians continue to struggle to access the very treatment plans we’ve developed. Meanwhile, the same model of care ...